Gå til indhold
Global sound
The Bio Report

The Bio Report

Unlocking Major Targets with Mini Proteins

· 25 min. · Episode 184

Episodebeskrivelse

Most small molecule drugs and biologics miss a large group of important receptors in the body. These receptors, known as GPCRs, play big roles in major diseases, but they are unusually hard to target in a precise and safe way. Skape Bio is trying to change that by using artificial intelligence to design an emerging class of therapies known as mini proteins that can fit these receptors snugly and control them in ways traditional drugs often can’t. Christoffer Norn, co‑founder and CEO of Skape Bio, discusses how mini proteins share strengths of both small molecules and biologics while avoiding some of their weaknesses, why the company’s approach could open up new therapeutic opportunities, and how Skape Bio is building a broad pipeline of differentiated GPCR‑targeting therapies.

Website: thebioreport.podbean.com

Live, seneste time: 10.615 sange på 4.500 stationer i 125 lande

Opdag verden gennem radioen

Flere måder at opdage på (9)

Hørt noget godt? Gem det, eller åbn det direkte i Spotify.

★ Artist of the week The fastest riser on the radio this week
Your song here? From € 9 per week →
1000 Jazz HitsFortsæt med at lytte